SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9030The trouble is that the trial would have to be very large because the event rateBiomaven-11/21/2005
9029Something for SEPR to think about in the future. Run an A vs. Foradil safety trkenhott-11/21/2005
9028The closest in size to Lunesta I see in the numbers I have is Advair, which had Biomaven-11/21/2005
9027I was traveling on b, stressed out, and underslept, so I provisioned for some L quidditch-11/21/2005
9026If you "correct" July to 350k (it clearly was an aberration), then theBiomaven-11/21/2005
9025Likely this warning will apply to SEPR's arformoterol as well - once you havBiomaven-11/21/2005
9024ot- replying to private message The extreme downside case for BIIB is T better kenhott-11/21/2005
9023Glaxo shares fall on FDA Advair proposal Monday November 21, 5:20 am ET By Ben Hrichardred-11/21/2005
9022Xopenex always sounded great to me too (I'm an albuterol junkie) but the sidMike McFarland-11/20/2005
9021<i>xopenex superior on cardiac safety</i> Would be exceedingly diffBiomaven-11/20/2005
9020I see SEPR being on the other side of the balance now regarding definitive trialkenhott-11/19/2005
9019When I first bought into sepr ages ago, one of the ideas was with a safer purifirkrw-11/18/2005
9018Monthly scripts: March 749 April 101,879 May 235,770 June 299,985 July 323,274 Rocky9-11/18/2005
9017The actual advisory =================== FDA Public Health Advisory Serevent Diskenhott-11/18/2005
9016LONDON, Nov 18 (Reuters) - Europe's biggest drugmaker GlaxoSmithKline (GSK.Lquidditch-11/18/2005
9015Just back from traveling and saw this late week GS comment: <<Market growquidditch-11/18/2005
9014So we are likely only a few weeks away from a $500m annual run rate. (120k/week Biomaven-11/14/2005
9013Another great week. Incredible launch continues.Harold Engstrom-11/14/2005
9012114,806 for 11/4 week. Up from 112,525 and 113,014. So up 2% WoW, and 1.5% from Rocky9-11/14/2005
9011<garbage results> Agreed. About 50% of the drug patients considered were Biomaven-11/14/2005
9010this is what we call a garbage pail article. Mixing varying older drugs and obtaIamarangerboy-11/14/2005
9009Sleeping Pill Risks May Outweigh Benefits In Older Patients By Jeff Minerd, MeIcebrg-11/14/2005
9008Do you realize it is probably easier to go to the sepracor site and read the preRobohogs-11/11/2005
9007What is Sepracor's "collaboration" with Acadia Pharma? Please elajrjdr-11/11/2005
9006Products & Profits: Ambien [WSJ] The product: A prescription sleep aid aimeDoc Bones-11/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News